318010 — Pharmsville Co Share Price
0.000.00%
Last trade - 00:00- KR₩26bn
- -KR₩13bn
- KR₩17bn
- 90
- 43
- 38
- 62
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.4 | ||
| Price to Tang. Book | 0.41 | ||
| Price to Free Cashflow | 7,705.98 | ||
| Price to Sales | 1.98 | ||
| EV to EBITDA | -181.14 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.76% | ||
| Return on Equity | 4.67% | ||
| Operating Margin | -3.79% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 39,408.55 | 39,027.51 | 26,113.22 | 21,394.73 | 16,724.98 | n/a | n/a | -11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -66.11 | +72.06 | -19.4 | -17.02 | -41.1 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pharmsville Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of manufacture, distribution, and sales of health functional foods. The Company is mainly engaged in the manufacture and sale of healthy functional foods and health-oriented foods, primarily through e-commerce and distribution platforms, and operates distribution business under its own brands. The Company manufactures and sells healthy functional foods including those for weight management, inner beauty, joint and bone health, digestive and eye health, nutritional supplements, and immune and antioxidant support.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2025
- Incorporated
- March 15th, 2000
- Public Since
- October 22nd, 2019
- No. of Shareholders
- 2,547
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 7,728,118
- Address
- 37, Magokjungang 8-ro 3-gil, Gangseo-gu, SEOUL, 07793
- Web
- http://pharmsville.net/
- Phone
- +82 25531323
- Auditors
- Daejoo Accounting Corp.
Upcoming Events for 318010
Similar to 318010
Asia Seed Co
Korea Exchange - KOSDAQ
Bifido Co
Korea Exchange - KOSDAQ
Bio Port Korea
Korea Exchange - KOSDAQ
BL PharmTech
Korea Exchange - KOSDAQ
ByOn Co
Korea Exchange - KOSDAQ
FAQ
What is the Pharmsville Co share price?
As of Today at 21:38 UTC, shares in Pharmsville Co are trading at KR₩3,425. This share price information is delayed by 15 minutes.
How has the Pharmsville Co share price performed this year?
Shares in Pharmsville Co last closed at KR₩3,425 and the price had moved by -16.16% over the past 365 days. In terms of relative price strength the Pharmsville Co share price has underperformed the FTSE Developed Asia Pacific Index by -33.52% over the past year.
What are the analyst and broker recommendations for Pharmsville Co?
The overall consensus recommendation for Pharmsville Co is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Pharmsville Co dividend yield?
The Pharmsville Co dividend yield is 2.92% based on the trailing twelve month period.
Does Pharmsville Co pay a dividend?
Last year, Pharmsville Co paid a total dividend of KR₩100, and it currently has a trailing dividend yield of 2.92%. We do not have any data on when Pharmsville Co is to next pay dividends.
When does Pharmsville Co next pay dividends?
We do not have data on when Pharmsville Co is to next pay dividends. The historic dividend yield on Pharmsville Co shares is currently 2.92%.
How do I buy Pharmsville Co shares?
To buy shares in Pharmsville Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Pharmsville Co?
As of the previous close price of KR₩3,425, shares in Pharmsville Co had a market capitalisation of KR₩26bn.
Where are Pharmsville Co shares listed?
Here are the trading details for Pharmsville Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 318010
What kind of share is Pharmsville Co?
Based on an overall assessment of its quality, value and momentum Pharmsville Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Pharmsville Co share price forecast for 2025?
The analyst consensus target price for shares in Pharmsville Co is KR₩20,700. That is 504.38% above the last closing price of KR₩3,425.
Analysts covering Pharmsville Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Pharmsville Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharmsville Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -21.46%.
As of the last closing price of KR₩3,425, shares in Pharmsville Co were trading -9.74% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Pharmsville Co PE Ratio?
The Pharmsville Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩3,425.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Pharmsville Co?
We do not have data on Pharmsville Co's directors